IL6 and metabolic syndrome: Finally, IL-6, a metabolic syndrome and atherosclerosis-related inflammatory marker could be of value in clinical practice as an indicator (together with HgbA1c) of the efficacy of the treatment as well as of the efficacy of preventive action on atherosclerosis.